Effectiveness and Safety of Sequential Triple Combination Therapy (Amlodipine/Losartan/Chlorthalidone) in Korean Patients With Hypertension
Key facts
- Where
- Gyeonggi-do, South KoreaSee the site
Where in South Korea
- Yongin Severance HospitalGyeonggi-do, South KoreaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Hanmi Pharmaceutical Company Limited
- Trial code
- NCT07784296
- Record updated
- 25 August 2026
- Original description
A multicenter, prospective, non-interventional, observational study to evaluate effectiveness and safety of sequential triple combination therapy (amlodipine/losartan/chlorthalidone) in Korean patients with hypertensionRead full original descriptionShow less
A Multicenter, Prospective, Non-interventional, Observational Study to Evaluate Effectiveness and Safety of Sequential Triple Combination Therapy (Amlodipine/Losartan/Chlorthalidone) in Korean Patients With Hypertension
A multicenter, prospective, non-interventional, observational study to evaluate effectiveness and safety of sequential triple combination therapy (amlodipine/losartan/chlorthalidone) in Korean patients with hypertension
Inclusion: Korean patients aged 19 years or older diagnosed with hypertension; Individuals newly diagnosed with hypertension or currently taking a single antihypertensive drug; Individuals for whom administration of Amoprel tablets has been determined based on the researcher's medical judgment; Individuals who have heard an explanation of this study and have voluntarily given written consent to participate in the study.
Exclusion: Individuals falling under the contraindications listed in the precautions for use of Amoprel Tab. or Amozartan Plus Tab; Pregnant women, women who may be pregnant, and nursing mothers; Individuals currently participating in an interventional study; Individuals deemed unsuitable for participation in this study by the researcher for other reasons.